RPL39 and glioma: To explore the function of RPL39 in glioma, siRPL39 and Flag-RPL39 plasmids were used to specifically knock down and overexpress RPL39, respectively, and western blotting was performed to assess the efficacy of the plasmids (Figure 11A).